S&P Futures
4,163.75 -12.00 (-0.29%) Dow Futures
34,119.00 -87.00 (-0.25%) Nasdaq Futures
12,744.50 -32.25 (-0.25%) Russell 2000 Futures
1,970.90 -8.40 (-0.42%) Crude Oil
77.47 +0.33 (+0.43%) Gold
1,896.30 +11.50 (+0.61%)
Personalis, Inc. (PSNL)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.8800 |
| Open | 3.9200 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 900 |
| Day's Range | 3.8000 - 4.2200 |
| 52 Week Range | 1.7300 - 12.9600 |
| Volume | |
| Avg. Volume | 539,515 |
| Market Cap | 191.701M |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3760 |
| Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.60 |
- Insider Monkey
15 Worst Stock Picks of Cathie Wood in 2022
In this piece, we will take a look at the 15 worst stock picks of Cathie Wood in 2022. For her top five worst stock picks, head on over to 5 Worst Stock Picks of Cathie Wood in 2022. Cathie Wood is one of the more popular hedge fund investors when it comes to the […]
- Business Wire
Personalis to Participate at Upcoming Investor Conferences
FREMONT, Calif., February 06, 2023--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the following investor conferences:
- Benzinga
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
Needham has upgraded Personalis Inc (NASDAQ: PSNL) to Buy from Hold with a price target of $8. The analyst writes that Personalis's cash burn has likely peaked and expects it to decline steadily over the next few years. Needham writes that PSNL used $41 million of cash in 3Q22, up from $33 million in 2Q22, and a significant portion of its new facility expenses ($38 million in 2022) fell into 3Q22. The company used $121 million in 2022, up from $78 million in 2021 (down from its initial expectati
